Crossmark

Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation

Published Online: 2022-03-23

Published Print: 2022-04

Authors

Jo, Wol Soon

Kim, Sung Dae

Jeong, Soo Kyung

Oh, Su Jung

ParK, Moon Taek

Lee, Chang Geun

Kang, Young- Rok

Jeong, Min Ho
Funding

Funding for this research was provided by:

Dong-A University Research Fund
License Information

Text and Data Mining valid from 2022-03-23

Version of Record valid from 2022-03-23
More Information

Article History

Received: 1 June 2021

Revised: 6 February 2022

Accepted: 13 February 2022

First Online: 23 March 2022

Declarations

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest.

Document is current